Form 8-K Mirum Pharmaceuticals, For: Dec 19
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Mirum sues generic drugmakers over Livmarli patent infringement
December 19, 2025 4:08 PM ESTMirum Pharmaceuticals Inc. (NASDAQ: MIRM) filed patent infringement lawsuits on December 19, 2025, against four generic drug manufacturers in the United States District Court for the District of Delaware.
The company sued Sandoz Inc., Annora Pharma Private Limited, Zydus Lifesciences Global FZE, and Zenara Pharma Private... More
